Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular Phenotype
Open Access
- 30 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e77748
- https://doi.org/10.1371/journal.pone.0077748
Abstract
Fetal growth restriction (FGR) is defined as the inability of a fetus to achieve its genetic growth potential and is associated with a significantly increased risk of morbidity and mortality. Clinically, FGR is diagnosed as a fetus falling below the 5th centile of customised growth charts. Sildenafil citrate (SC, Viagra™), a potent and selective phosphodiesterase-5 inhibitor, corrects ex vivo placental vascular dysfunction in FGR, demonstrating potential as a therapy for this condition. However, many FGR cases present without an abnormal vascular phenotype, as assessed by Doppler measures of uterine/umbilical artery blood flow velocity. Thus, we hypothesized that SC would not increase fetal growth in a mouse model of FGR, the placental-specific Igf2 knockout mouse, which has altered placental exchange capacity but normal placental blood flow. Fetal weights were increased (by 8%) in P0 mice following maternal SC treatment (0.4 mg/ml) via drinking water. There was also a trend towards increased placental weight in treated P0 mice (P = 0.056). Additionally, 75% of the P0 fetal weights were below the 5th centile, the criterion used to define human FGR, of the non-treated WT fetal weights; this was reduced to 51% when dams were treated with SC. Umbilical artery and vein blood flow velocity measures confirmed the lack of an abnormal vascular phenotype in the P0 mouse; and were unaffected by SC treatment. 14C-methylaminoisobutyric acid transfer (measured to assess effects on placental nutrient transporter activity) per g placenta was unaffected by SC, versus untreated, though total transfer was increased, commensurate with the trend towards larger placentas in this group. These data suggest that SC may improve fetal growth even in the absence of an abnormal placental blood flow, potentially affording use in multiple sub-populations of individuals presenting with FGR.Keywords
This publication has 48 references indexed in Scilit:
- Comparative analysis of placental vasculature and placental volume in normal and IUGR pregnancies with the use of three-dimensional Power DopplerArchiv für Gynäkologie, 2011
- Placental-specific Igf2 knockout mice exhibit hypocalcemia and adaptive changes in placental calcium transportProceedings of the National Academy of Sciences of the United States of America, 2010
- Fetal Growth RestrictionSeminars in Perinatology, 2008
- Placental System A Amino Acid Transport is Reduced in Pregnancies With Small For Gestational Age (SGA) Infants but Not in Preeclampsia with SGA InfantsPlacenta, 2008
- Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular RestenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Increased maternofetal calcium flux in parathyroid hormone‐related protein‐null miceThe Journal of Physiology, 2008
- Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysisCMAJ : Canadian Medical Association Journal, 2008
- Market Failure and the Poverty of New Drugs in Maternal HealthPLoS Medicine, 2008
- Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein dietThe Journal of Physiology, 2006
- Association between the Activity of the System A Amino Acid Transporter in the Microvillous Plasma Membrane of the Human Placenta and Severity of Fetal Compromise in Intrauterine Growth RestrictionPediatric Research, 1997